Compare ARK Genomic Revolution ETF (ARKG) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Eli Lilly And Co — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while Eli Lilly And Co trades at $1,214.93 (market cap $1.08T). The key difference: Eli Lilly And Co pays a 0.57% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | LLY | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $1.24K |
52-Week Low | $24.02 | $639.43 |
Market Cap | — | $1.08T |
Enterprise Value | — | $1.13T |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
